31 – 40 of 59
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2005
-
Mark
BCL11B functionally associates with the NuRD complex in T lymphocytes to repress targeted promoter
(
- Contribution to journal › Article
-
Mark
ERK1/2 inhibition increases antiestrogen treatment efficacy by interfering with hypoxia-induced downregulation of ERalpha: a combination therapy potentially targeting hypoxic and dormant tumor cells.
(
- Contribution to journal › Article
-
Mark
Microarray analyses reveal strong influence of DNA copy number alterations on the transcriptional patterns in pancreatic cancer: implications for the interpretation of genomic amplifications.
(
- Contribution to journal › Article
-
Mark
Wnt-5a has tumor suppressor activity in thyroid carcinoma
(
- Contribution to journal › Article
-
Mark
The role of Smad signaling in hematopoiesis.
(
- Contribution to journal › Scientific review
-
Mark
ERK phosphorylation is linked to VEGFR2 expression and Ets-2 phosphorylation in breast cancer and is associated with tamoxifen treatment resistance and small tumours with good prognosis
(
- Contribution to journal › Article
-
Mark
A role for cyclin A1 in mediating the autocrine expression of vascular endothelial growth factor in prostate cancer.
(
- Contribution to journal › Article
- 2004
-
Mark
Staf50 is a novel p53 target gene conferring reduced clonogenic growth of leukemic U-937 cells.
(
- Contribution to journal › Article
-
Mark
Regulation of the cyclin A1 protein is associated with its differential subcellular localization in hematopoietic and leukemic cells.
(
- Contribution to journal › Article
-
Mark
Microarray expression profiling in melanoma reveals a BRAF mutation signature
(
- Contribution to journal › Article